世界の感染症用体外診断薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Infectious Diseases In Vitro Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4363
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、感染症用体外診断薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRSA、連鎖球菌、結核＆薬剤耐性結核、消化器パネル検査、HIV、C型肝炎、その他）、用途別市場規模（免疫化学、分子診断、微生物学、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・感染症用体外診断薬の市場動向
・企業の競争状況、市場シェア
・感染症用体外診断薬の種類別市場規模と予測2016-2027（MRSA、連鎖球菌、結核＆薬剤耐性結核、消化器パネル検査、HIV、C型肝炎、その他）
・感染症用体外診断薬の用途別市場規模と予測2016-2027（免疫化学、分子診断、微生物学、その他）
・感染症用体外診断薬の北米市場規模2016-2027（アメリカ、カナダ）
・感染症用体外診断薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・感染症用体外診断薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・感染症用体外診断薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・感染症用体外診断薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BD、Abbott、Alere、Quidel、F. Hoffmann-La Roche、Orasure Technologies、Cepheid、Hologic、Qiagen、Bio-Rad Laboratories、Siemens Healthcare）
・結論

Market Analysis and Insights: Global Infectious Diseases In Vitro Diagnostics Market
The global Infectious Diseases In Vitro Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Diseases In Vitro Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Diseases In Vitro Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Diseases In Vitro Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Diseases In Vitro Diagnostics market.

Global Infectious Diseases In Vitro Diagnostics Scope and Market Size
Infectious Diseases In Vitro Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Diseases In Vitro Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others

Segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2016-2027)
2.2 Infectious Diseases In Vitro Diagnostics Growth Trends by Regions
2.2.1 Infectious Diseases In Vitro Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Diseases In Vitro Diagnostics Industry Dynamic
2.3.1 Infectious Diseases In Vitro Diagnostics Market Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue
3.1.1 Global Top Infectious Diseases In Vitro Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Diseases In Vitro Diagnostics Revenue
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2020
3.5 Infectious Diseases In Vitro Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Diseases In Vitro Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2022-2027)

5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2016-2027)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type
6.2.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2027)
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Application
6.3.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2027)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country
6.4.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2016-2027)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type
7.2.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2027)
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application
7.3.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2027)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country
7.4.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type
8.2.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application
8.3.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region
8.4.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size (2016-2027)
9.2 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type
9.2.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application
9.3.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country
9.4.1 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type
10.2.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application
10.3.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country
10.4.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.1.5 BD Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.3.5 Alere Recent Development
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.4.5 Quidel Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Details
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.6.5 Orasure Technologies Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.8.5 Hologic Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.9.5 Qiagen Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
11.11.5 Siemens Healthcare Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MRSA
Table 3. Key Players of Streptococcus
Table 4. Key Players of TB and Drug-resistant TB
Table 5. Key Players of Gastro-intestinal Panel Testing
Table 6. Key Players of HIV
Table 7. Key Players of Hepatitis C
Table 8. Key Players of Others
Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Regions (2016-2021)
Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Regions (2022-2027)
Table 15. Infectious Diseases In Vitro Diagnostics Market Trends
Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers
Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges
Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints
Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players (2016-2021)
Table 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2020)
Table 22. Ranking of Global Top Infectious Diseases In Vitro Diagnostics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Infectious Diseases In Vitro Diagnostics Product Solution and Service
Table 26. Date of Enter into Infectious Diseases In Vitro Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2016-2021)
Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2016-2021)
Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Infectious Diseases In Vitro Diagnostics Product
Table 69. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 70. BD Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Infectious Diseases In Vitro Diagnostics Product
Table 74. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Alere Company Details
Table 77. Alere Business Overview
Table 78. Alere Infectious Diseases In Vitro Diagnostics Product
Table 79. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Alere Recent Development
Table 81. Quidel Company Details
Table 82. Quidel Business Overview
Table 83. Quidel Infectious Diseases In Vitro Diagnostics Product
Table 84. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Quidel Recent Development
Table 86. F. Hoffmann-La Roche Company Details
Table 87. F. Hoffmann-La Roche Business Overview
Table 88. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product
Table 89. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 90. F. Hoffmann-La Roche Recent Development
Table 91. Orasure Technologies Company Details
Table 92. Orasure Technologies Business Overview
Table 93. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product
Table 94. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Orasure Technologies Recent Development
Table 96. Cepheid Company Details
Table 97. Cepheid Business Overview
Table 98. Cepheid Infectious Diseases In Vitro Diagnostics Product
Table 99. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 100. Cepheid Recent Development
Table 101. Hologic Company Details
Table 102. Hologic Business Overview
Table 103. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Hologic Recent Development
Table 105. Qiagen Company Details
Table 106. Qiagen Business Overview
Table 107. Qiagen Infectious Diseases In Vitro Diagnostics Product
Table 108. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Qiagen Recent Development
Table 110. Bio-Rad Laboratories Company Details
Table 111. Bio-Rad Laboratories Business Overview
Table 112. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product
Table 113. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Bio-Rad Laboratories Recent Development
Table 115. Siemens Healthcare Company Details
Table 116. Siemens Healthcare Business Overview
Table 117. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product
Table 118. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Siemens Healthcare Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. MRSA Features
Figure 3. Streptococcus Features
Figure 4. TB and Drug-resistant TB Features
Figure 5. Gastro-intestinal Panel Testing Features
Figure 6. HIV Features
Figure 7. Hepatitis C Features
Figure 8. Others Features
Figure 9. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2020 VS 2027
Figure 10. Immunochemistry Case Studies
Figure 11. Molecular Diagnostics Case Studies
Figure 12. Microbiology Case Studies
Figure 13. Others Case Studies
Figure 14. Infectious Diseases In Vitro Diagnostics Report Years Considered
Figure 15. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Infectious Diseases In Vitro Diagnostics Market Share by Regions: 2020 VS 2027
Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Share by Regions (2022-2027)
Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2020
Figure 20. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2020
Figure 22. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2016-2021)
Figure 23. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2022-2027)
Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Infectious Diseases In Vitro Diagnostics Market Share by Type (2016-2027)
Figure 26. North America Infectious Diseases In Vitro Diagnostics Market Share by Application (2016-2027)
Figure 27. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2016-2027)
Figure 28. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Infectious Diseases In Vitro Diagnostics Market Share by Type (2016-2027)
Figure 32. Europe Infectious Diseases In Vitro Diagnostics Market Share by Application (2016-2027)
Figure 33. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2016-2027)
Figure 34. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Share by Region (2016-2027)
Figure 44. China Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Type (2016-2027)
Figure 52. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Application (2016-2027)
Figure 53. Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2016-2027)
Figure 54. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Share by Country (2016-2027)
Figure 60. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 64. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 65. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 66. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 67. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 68. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 69. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 70. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 71. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 72. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 73. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

以下、関連資料のご紹介

世界のIVD感染症市場規模・現状・予測（2021年-2027年）

Global IVD Infectious Diseases Market Size, Status and Forecast 2021-2027
QFJ1-4399 2021年6月 116Pages
QYResearch社発行の本調査レポートでは、IVD感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫化学、分子診断）、用途別市場規模（臨床検査室、診断センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の体外診断用酵素市場規模・現状・予測（2021年-2027年）

Global In-vitro Diagnostics Enzymes Market Size, Status and Forecast 2021-2027
QFJ1-4396 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、体外診断用酵素の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロテアーゼ、ポリメラーゼ＆トランスクリプターゼ、リボヌクレアーゼ、その他）、用途別市場規模（製薬・バイオテクノロジー、病院・診断研究所、...

世界のIVD（体外診断）製品市場規模・現状・予測（2021年-2027年）

Global IVD (In Vitro Diagnostics) Products Market Size, Status and Forecast 2021-2027
QFJ1-5219 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、IVD（体外診断）製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫診断、分子診断、組織診断、その他）、用途別市場規模（病院、研究所、研究・学術、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の体外診断（IVD）市場規模・現状・予測（2021年-2027年）

Global In Vitro Diagnostics(IVD) Market Size, Status and Forecast 2021-2027
QFJ1-4357 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、体外診断（IVD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（試薬、機器、ソフトウェア＆サービス）、用途別市場規模（独立研究室、病院、大学＆医学部、ポイントオブケア検査、その他）、主要地域別市場規...

世界の医療関連感染症診断市場規模・現状・予測（2021年-2027年）

Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4288 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、医療関連感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿路感染症、手術部位感染症、院内肺炎、菌血症、胃腸感染症）、用途別市場規模（病院、診療所、ASC）、主要地域別市場規模（北米、アメリカ...

世界の体外診断用医薬品(IVD)用品質管理製品市場規模・現状・予測（2021年-2027年）

Global In Vitro Diagnostics (IVD) Quality Control Product Market Size, Status and Forecast 2021-2027
QFJ1-4356 2021年6月 122Pages
QYResearch社発行の本調査レポートでは、体外診断用医薬品(IVD)用品質管理製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（品質管理製品、品質保証サービス、データ管理ソリューション）、用途別市場規模（生化学、免疫化学、血液学、分子診断学...

世界の感染症用診療現場診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4362 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、感染症用診療現場診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（店頭（OTC）検査キット、処方箋ベース検査キット）、用途別市場規模（細菌感染症、真菌感染症、ウイルス感染症、心血管感染症、胃腸感染症...

世界のポイントオブケア感染症市場規模・現状・予測（2021年-2027年）

Global Point of Care Infectious Disease Market Size, Status and Forecast 2021-2027
QFJ1-4724 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、ポイントオブケア感染症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC...

世界の感染症診断市場規模・現状・予測（2021年-2027年）

Global Infectious Disease Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4361 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、感染症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（尿、血液、その他）、用途別市場規模（病院＆外傷センター、診断研究所、リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の体外診断 (IVD) キット市場規模・現状・予測（2021年-2027年）

Global In Vitro Diagnostic (IVD) Kit Market Size, Status and Forecast 2021-2027
QFJ1-5208 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、体外診断 (IVD) キットの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫診断、化学診断、分子診断、POCT、その他）、用途別市場規模（病院、実験室、その他）、主要地域別市場規模（北米、アメリカ...

世界のIVD感染症市場規模・現状・予測（2021年-2027年） In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease. Market Analysis and Insights: Global IVD Infe…
世界の医療関連感染症診断市場規模・現状・予測（2021年-2027年） Diagnosis of health care-associated infectious diseases. Diagnosis of health care-associated infectious diseases. Market Analysis and Insights: Global Healthcare-associated Infectious Disease Diagnostics Market The global Healthcare-associated Infectious Disease Diagnostics market size is projected …
世界のIVD（体外診断）製品市場規模・現状・予測（2021年-2027年） A series of test products that done on samples such as blood or tissue that have been taken from the human body. Market Analysis and Insights: Global IVD (In Vitro Diagnostics) Products Market The global IVD (In Vitro Diagnostics) Products market size is projected to reach US$ XX million by 2027, fr…
世界の体外診断（IVD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics(IVD) Market The global In Vitro Diagnostics(IVD) market size is projected to reach US$ 120900 million by 2027, from US$ 76910 million in 2020, at a CAGR of 6.6% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の体外診断用医薬品(IVD)用品質管理製品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics (IVD) Quality Control Product Market The global In Vitro Diagnostics (IVD) Quality Control Product market size is projected to reach US$ 918.2 million by 2027, from US$ 776 million in 2020, at a CAGR of 2.0% during 2021-2027. With industry-st…